DOI:
10.1055/s-00034915
Onkologische Welt
LinksClose Window
References
De Wit R. et al
Cabazitaxel versus abiraterone or enzalutamide in metastatic prostate cancer..
N Engl J Med 2019;
381: 2506-2518
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.